|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oversikt over luftvegsprøver, Mikrobiologisk
avdeling, HUS. |
2020-2021 |
|
|
Inneliggjande pasientar |
Veke 21-20 |
|
Veke 21-19 |
|
Veke 21-18 |
|
Veke 21-17 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
141 |
<5 |
|
|
149 |
<5 |
|
|
173 |
<5 |
|
|
156 |
<5 |
|
|
|
Bordetella parapertussis |
141 |
<5 |
|
|
149 |
<5 |
|
|
173 |
<5 |
|
|
156 |
<5 |
|
|
|
Mycoplasma pneumoniae |
141 |
<5 |
|
|
149 |
<5 |
|
|
173 |
<5 |
|
|
156 |
<5 |
|
|
|
Chlamydia pneumoniae |
141 |
<5 |
|
|
149 |
<5 |
|
|
173 |
<5 |
|
|
156 |
<5 |
|
|
|
Influensavirus A |
300 |
<5 |
|
|
305 |
<5 |
|
|
327 |
<5 |
|
|
271 |
<5 |
|
|
|
Influensavirus B |
300 |
<5 |
|
|
305 |
<5 |
|
|
327 |
<5 |
|
|
271 |
<5 |
|
|
|
Parainfluensavirus 1 |
141 |
<5 |
|
|
149 |
<5 |
|
|
173 |
<5 |
|
|
156 |
<5 |
|
|
|
Parainfluensavirus 2 |
141 |
<5 |
|
|
149 |
<5 |
|
|
173 |
<5 |
|
|
156 |
<5 |
|
|
|
Parainfluensavirus 3 |
141 |
<5 |
|
|
149 |
<5 |
|
|
173 |
<5 |
|
|
156 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
230 |
<5 |
|
|
234 |
<5 |
|
|
274 |
<5 |
|
|
224 |
<5 |
|
|
|
Humant metapneumovirus |
141 |
<5 |
|
|
149 |
<5 |
|
|
173 |
<5 |
|
|
156 |
<5 |
|
|
|
Rhinovirus |
141 |
9 |
6 % |
|
149 |
8 |
5 % |
|
173 |
8 |
5 % |
|
156 |
6 |
4 % |
|
|
SARS-CoV-2 |
410 |
<5 |
|
|
439 |
<5 |
|
|
455 |
<5 |
|
|
425 |
5 |
1 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ambulante pasientar |
Veke 21-20 |
|
Veke 21-19 |
|
Veke 21-18 |
|
Veke 21-17 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
141 |
<5 |
|
|
169 |
<5 |
|
|
199 |
<5 |
|
|
187 |
<5 |
|
|
|
Bordetella parapertussis |
141 |
<5 |
|
|
169 |
<5 |
|
|
199 |
<5 |
|
|
187 |
<5 |
|
|
|
Mycoplasma pneumoniae |
141 |
<5 |
|
|
169 |
<5 |
|
|
199 |
<5 |
|
|
187 |
<5 |
|
|
|
Chlamydia pneumoniae |
141 |
<5 |
|
|
169 |
<5 |
|
|
199 |
<5 |
|
|
187 |
<5 |
|
|
|
Influensavirus A |
155 |
<5 |
|
|
174 |
<5 |
|
|
215 |
<5 |
|
|
193 |
<5 |
|
|
|
Influensavirus B |
155 |
<5 |
|
|
174 |
<5 |
|
|
215 |
<5 |
|
|
193 |
<5 |
|
|
|
Parainfluensavirus 1 |
141 |
<5 |
|
|
169 |
<5 |
|
|
199 |
<5 |
|
|
187 |
<5 |
|
|
|
Parainfluensavirus 2 |
141 |
<5 |
|
|
169 |
<5 |
|
|
199 |
<5 |
|
|
187 |
<5 |
|
|
|
Parainfluensavirus 3 |
141 |
<5 |
|
|
169 |
<5 |
|
|
199 |
<5 |
|
|
187 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
154 |
<5 |
|
|
172 |
<5 |
|
|
215 |
<5 |
|
|
192 |
<5 |
|
|
|
Humant metapneumovirus |
141 |
<5 |
|
|
169 |
<5 |
|
|
199 |
<5 |
|
|
187 |
<5 |
|
|
|
Rhinovirus |
141 |
22 |
16 % |
|
169 |
34 |
20 % |
|
199 |
45 |
23 % |
|
187 |
30 |
16 % |
|
|
SARS-CoV-2 |
14277 |
155 |
1 % |
|
14278 |
193 |
1 % |
|
15840 |
309 |
2 % |
|
14655 |
232 |
2 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inneliggjande pasientar omfatter fleire
sjukehus i vår region |
|
|
|
|
|
|
|
27.05.2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|